NCT05426291

Brief Summary

Aimed to determine whether preoperative biomarkers (Mg, Hgb, CRP, ProBNP) would be helpful in the early diagnosis of CSA-AKI (cardiac surgery-related acute kidney injury) in patients undergoing open heart surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

September 30, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

June 17, 2024

Status Verified

June 1, 2024

Enrollment Period

1.2 years

First QC Date

April 18, 2022

Last Update Submit

June 14, 2024

Conditions

Keywords

Open Heart Surgery

Outcome Measures

Primary Outcomes (2)

  • The requirement of continue venovenous hemodiafiltration (CVVHDF)

    After on pump surgery resulting AKI may require CVVHDF(pH\<7.21, urine output \< 0.5 ml/kg during 6 hours, potassium \> 6 mEq/L)

    Immediately after surgery

  • Predict acute renal failure in on-pomp conary artery bypass via preoperative biomarkers

    To detect acute kidney injury in the early period in open heart surgery and to take precautions

    up to postoperative 28th day

Secondary Outcomes (1)

  • The requirement of hemodialysis during postoperative 28 days

    up to postoperative 28th day

Study Arms (2)

Group I

At least two of the preoperative biomarkers (Mg\<0.85 mmol/L, Hgb\<8.5 mmol/L, proBNP\>480 pg/mL, CRP\>5 mg/L) that are thought to be closely related to acute kidney injury after cardiac surgery Group I,

Other: BIOMARKER LEVELS IS IT POSSIBLE TO PREDICT ACUTE RENAL DAMAGE IN THE PREOP PERIOD?

Group II

Patients who meet at least two of the preoperative biomarkers (Mg\>0.85 mmol/L, Hgb\>8.5 mmol/L, proBNP\<480 pg/mL, CRP\<5 mg/L) Group II .

Other: BIOMARKER LEVELS IS IT POSSIBLE TO PREDICT ACUTE RENAL DAMAGE IN THE PREOP PERIOD?

Interventions

In open heart surgery, it will be followed whether acute kidney injury will develop by looking at the biomarkers in the preoperative period.

Group IGroup II

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients (aged ≥40 years,\<85 years) with ASA II-IV who were scheduled for elective open heart surgery under cardiopulmonary bypass (CPB) will be prospectively included in this study. Patients included in the study will be divided into two groups. At least two of the preoperative biomarkers (Mg\<0.85 mmol/L, Hgb\<8.5 mmol/L, proBNP\>480 pg/mL, CRP\>5 mg/L) that are thought to be closely related to acute kidney injury after cardiac surgery Group I, patients who meet at least two of the preoperative biomarkers (Mg\>0.85 mmol/L, Hgb\>8.5 mmol/L, proBNP\<480 pg/mL, CRP\<5 mg/L) Group II will be included in the study.

You may qualify if:

  • Elective on-pomp coronary artery bypass

You may not qualify if:

  • Emergency operation,
  • Off pump coronary artery bypass
  • Revision (repetitive) operation
  • Preoperative acute Renal failure
  • Preoperative chronic Renal failure
  • Preoperative decompansed heart failure
  • Valve replacement surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BakirkoySadiKonuk Training and Searching Hospital

Istanbul, 34147, Turkey (Türkiye)

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

cystatin c level will be checked in the blood sample taken from the patient

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Gülsüm Oya HERGÜNSEL, Ass. Prof.

    Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 18, 2022

First Posted

June 21, 2022

Study Start

September 30, 2022

Primary Completion

November 30, 2023

Study Completion

May 30, 2024

Last Updated

June 17, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations